Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

Gene

Volumn 238, Issue 2, 1999, Pages 375-385

  Schummer, Michèl ^a   Ng, WaiLap V ^a   Bumgarner, Roger E ^a   Nelson, Peter S ^a   Schummer, Bernhard ^b   Bednarski, David W ^a   Hassell, Laurie ^a   Baldwin, Rae Lynn ^c   Karlan, Beth Y ^c   Hood, Leroy ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer maker; Differential expression; DNA array; HE4

Indexed keywords

COMPLEMENTARY DNA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CLONE CELLS; DNA, COMPLEMENTARY; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032848246     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00342-X     Document Type: Article

References (32)

1. Cancer Facts and Figures. 1998;American Cancer Society, Atlanta, GA.
2. Baselga J., Norton L., Albanell J., Kim Y.M., Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58:1998;2825-2831.
3. Berchuck A., Kohler M.F., Bast R.C. Jr. Molecular genetic features of ovarian cancer. Prog. Clin. Biol. Res. 394:1996;269-284.
4. Bishop J.O., Morton J.G., Rosbash M., Richardson M. Three abundance classes in HeLa cell messenger RNA. Nature. 250:1974;199-204.
5. Blomberg J., Andersson M., Faldt R. Differential pattern of oncogene and beta-actin expression in leukaemic cells from AML patients. Br. J. Haematol. 65:1987;83-86.
6. Couto J.R., Taylor M.R., Godwin S.G., Ceriani R.L., Peterson J.A. Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol. 15:1996;281-286.
7. Delabie J., Shipman R., Brüggen J., De Strooper B., van Leuven F., Tarcsay L., Cerletti N., Odink K., Diehl V., Bilbe G., et al. Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Blood. 80:1992;2891-2896.
8. Dong Y., Walsh M.D., Cummings M.C., Wright R.G., Khoo S.K., Parsons P.G., McGuckin M.A. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J. Pathol. 183:1997;311-317.
9. Falkenstein E., Meyer C., Eisen C., Scriba P.C., Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 229:1996;86-89.
10. Fishman D.A., Bafetti L.M., Banionis S., Kearns A.S., Chilukuri K., Stack M.S. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer. 80:1997;1457-1463.
11. Gaugitsch H.W., Prieschl E.E., Kalthoff F., Huber N.E., Baumruker T. A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA. J. Biol. Chem. 267:1992;11267-11273.
12. Isola J., Kallioniemi O.P., Korte J.M., Wahlstrom T., Aine R., Helle M., Helin H. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay and patient survival. J. Pathol. 162:1990;295-301.
13. Jacobs I., Davies A.P., Bridges J., Stabile I., Fay T., Lower A., Grudzinskas J.G., Oram D. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography [see comments]. Br. Med. J. 306:1993;1030-1034.
14. Karlan B.Y., Jones J., Greenwald M., Lagasse L.D. Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Am. J. Obstet. Gynecol. 173:1995;97-104.
15. Kauppila S., Saarela J., Stenback F., Risteli J., Kauppila A., Risteli L. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am. J. Pathol. 148:1996;539-548.
16. Khosravi-Far R., Solski P.A., Clark G.J., Kinch M.S., Der C.J. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:1995;6443-6453.
17. Kirchhoff C., Habben I., Ivell R., Krull N. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol. Reprod. 45:1991;350-357.
18. Kojima T., Inazawa J., Takamatsu J., Rosenberg R.D., Saito H. Human ryudocan core protein: molecular cloning and characterization of the cDNA, and chromosomal localization of the gene. Biochem. Biophys. Res. Commun. 190:1993;814-822.
19. Nakanishi K., Hashizume S., Kato M., Honjoh T., Setoguchi Y., Yasumoto K. Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Hum. Antibodies. 8:1997;189-194.
20. Naylor M.S., Stamp G.W., Balkwill F.R. Beta actin expression and organization of actin filaments in colorectal neoplasia. Epithelial Cell Biol. 1:1992;99-104.
21. Ng E.H., Ji C.Y., Tan P.H., Lin V., Soo K.C., Lee K.O. Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients [in process citation]. Ann. Surg. Oncol. 5:1998;194-201.
22. Ng W.L., Schummer M., Cirisano F., Baldwin R.L., Karlan B.Y., Hood L. High-throughput plasmid minipreparations facilitated by micro-mixing. Nucleic Acids Res. 24:1996;5045-5047.
23. Piétu G., Alibert O., Guichard V., Lamy B., Bois F., Leroy E., Mariage-Samson R.R.H., Soularue P., Auffray C. Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res. 6:1996;492-503.
24. Pogue-Geile K., Geiser J.R., Shu M., Miller C., Wool I.G., Meisler A.I., Pipas J.M. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol. Cell. Biol. 11:1991;3842-3849.
25. Rittenhouse H.G., Finlay J.A., Mikolajczyk S.D., Partin A.W. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate [in process citation]. Crit. Rev. Clin. Lab. Sci. 35:1998;275-368.
26. Schena M., Heller R.A., Theriault T.P., Konrad K., Lachenmeier E., Davis R.W. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. 16:1998;301-306.
27. ™ One Tube RT-PCR and capillary electrophoresis. Biochemica. 2:1998;31-33.
28. Schummer M., Ng W.-L., Nelson P.S., Bumgarner R.B., Hood L. A simple high-performance DNA arraying device for comparative expression analysis of a large number of genes. BioTechniques. 23:1997;1087-1092.
29. Stickeler E., Runnebaum I.B., Möbus V.J., Kieback D.G., Kreienberg R. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Anticancer Res. 17:1997;1871-1876.
30. Trower M.K., Orton S.M., Purvis I.J., Sanseau P., Riley J., Christodoulou C., Burt D., See C.G., Elgar G., Sherrington R., Rogaev E.I., St George-Hyslop P., Brenner S., Dykes C.W. Conservation of synteny between the genome of the pufferfish (Fugu rubripes) and the region on human chromosome 14 (14q24.3) associated with familial Alzheimer disease. Proc. Natl. Acad. Sci .USA. 93:1996;1366-1369.
31. Wolf D.A., Wang S., Panzica M.A., Bassily N.H., Thompson N.L. Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res. 56:1996;5012-5022.
32. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.